Mitogens and the Cell Cycle
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Treatment Resistant Cancers
Mutagenicity and Carcinogenicity
Cancer
Cancer-Critical Genes I: Proto-oncogenes
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 24, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
No abstract available in PubMed .